Wijziging van de Wet geneesmiddelenprijzen in verband met een aanpassing van de referentielanden

This legislative proposal aims to amend the current Medicines Prices Act. The core change involves adjusting the reference countries used for determining medicine prices. This amendment will affect pharmaceutical companies and potentially influence the prices of medicines for consumers. The specific impact depends on which countries are chosen as new references.